Danaher Corporation $DHR Shares Acquired by Cortland Associates Inc. MO

Cortland Associates Inc. MO increased its stake in Danaher Corporation (NYSE:DHR) by 0.1% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 172,273 shares of the conglomerate’s stock after acquiring an additional 105 shares during the quarter. Danaher makes up 4.0% of Cortland Associates Inc. MO’s holdings, making the stock its 12th largest holding. Cortland Associates Inc. MO’s holdings in Danaher were worth $34,031,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of DHR. MGO One Seven LLC boosted its position in shares of Danaher by 485.7% in the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after buying an additional 20,813 shares during the period. Chicago Capital LLC boosted its position in shares of Danaher by 11.6% in the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after buying an additional 1,391 shares during the period. UniSuper Management Pty Ltd boosted its position in shares of Danaher by 1.6% in the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after buying an additional 2,667 shares during the period. Asahi Life Asset Management CO. LTD. acquired a new stake in shares of Danaher in the first quarter worth $539,000. Finally, Horizon Financial Services LLC boosted its position in shares of Danaher by 20,400.0% in the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock worth $1,681,000 after buying an additional 8,160 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the business’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

DHR has been the subject of several recent analyst reports. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Danaher in a research report on Saturday, September 27th. Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 target price for the company in a research report on Friday, July 11th. Guggenheim reaffirmed a “buy” rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Finally, Wells Fargo & Company decreased their target price on Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 23rd. Seventeen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $246.74.

Danaher Price Performance

DHR opened at $208.63 on Wednesday. The stock has a market cap of $149.39 billion, a price-to-earnings ratio of 44.39, a PEG ratio of 3.02 and a beta of 0.77. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.41. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock has a fifty day moving average price of $200.40 and a 200 day moving average price of $197.32.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s payout ratio is currently 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.